6 Drug Stocks Unworthy of Biotech Bull Market

Description:

According to Adam Feuerstein, here are "six biotech and drug stocks with valuations reaching unsustainable levels or which, for various reasons, don't deserve an invitation to the biotech bull market party at all." Read more here.

>>Also: 6 Stocks With Double-Digits Gains and Big Dividends

>>Also: 3 Tech Turnaround Stocks for 2012

Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

5 Stocks Insiders Love Right Now

07.23.14 | 01:05 PM

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. >>Hedge Funds Hate These 5 Stocks -- ...

Hedge Funds Hate These 5 Stocks -- Should You?

07.23.14 | 10:50 AM

BALTIMORE (Stockpickr) -- There's nothing hedge fund managers love more than talking their books Professional investors relish every opportunity to...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter